画像診断サービス市場 : 2027年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2022年9月

画像診断サービス市場 : 処置(MRI、超音波、CT、X線、核画像、マンモグラフィ)、用途(OB/Gyn、骨盤/腹部、心臓病学、腫瘍学、神経学)、テクノロジー、ユーザー(病院、診断センター) – 2027年までの世界予測
Diagnostic Imaging Services Market by Procedure (MRI, Ultrasound, CT, X-RAY, Nuclear Imaging, Mammography), Application (OB/Gyn, Pelvic/Abdomen, Cardiology, Oncology, Neurology), Technology, User (Hospitals, Diagnostic Centers) – Global Forecast to 2027

ページ数 225
図表数 216
種別 英文調査報告書
価格

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

The diagnostic imaging services market is projected to reach USD 702.6 billion by 2027 from USD 549.0 billion in 2022, at a CAGR of 5.1% during the forecast period. Major factors driving the growth of market includes rising global incidence of various chronic diseases, growing awareness about the different imaging modalities, and growing expansion of outpatient imaging centers

Diagnostic Imaging Services Market by Procedure (MRI, Ultrasound, CT, X-RAY, Nuclear Imaging, Mammography), Application (OB/Gyn, Pelvic/Abdomen, Cardiology, Oncology, Neurology), Technology, User (Hospitals, Diagnostic Centers) - Global Forecast to 2027

However, high cost associated with diagnostic imaging equipment; reducing the adoption of new imaging technology among lower economic countries and shortage of skilled workforce is anticipated to restrain the growth of market.

“X-ray accounted for the largest share of the global diagnostic imaging services market in 2021”.
Based on Modality, the market is segmented into X-ray , computed tomography, ultrasound, MRI, nuclear imaging, and mammography. In 2021, the x-ray segment accounted for the largest share of the diagnostic imaging services market. This is attributed to the increased usage of digital X-ray imaging modality among hospitals & diagnostic centers across the globe. Additionally, ongoing technological upgradation in X-ray scan such as Hierarchical Phase-Contrast Tomography (HiP-CT) , offering 3D image of whole body scan with the resolution 10 times greater than CT scanner , are anticipated to support the growth of the segment in the near future.

“The neurology segment accounted for the largest share of the MRI imaging services market in 2021”.
Based on application, the MRI services market is segmented into neurology, orthopedics, cardiovascular, pelvic & abdomen, and oncology. The neurology segment accounted for the largest share of the MRI services market in 2021. This is attributed to the increased aged population and growing incidences of neurodegenerative disorders, traumatic brain injuries, advancements in MRI imaging technology and growing number of players introducing new MRI technology for prediction of various neurological disorders.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
The diagnostic imaging services market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, Latin America and Middle East & Africa. In 2021, North America commanded the largest share of the global diagnostic imaging service market. However, the Asia Pacific market is estimated to grow at the highest CAGR of 6.1%during the forecast period primarily due to the improving healthcare infrastructure, rising investments in diagnostic imaging, improving reimbursement scenario, rising medical tourism, and the growing insurance coverage in several APAC countries. Furthermore, establishment of new diagnostic centers and hospitals in Asian Countries are expected to propel the growth of market in the Asia Pacific during the forecast period.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 48%, Tier 2 – 36%, and Tier 3 – 16%
• By Designation: C-level – 10%, Director-level – 14%, and Others – 76%
• By Region: North America- 40%, Europe – 32%, APAC – 20%, and RoW – 8%

The major player in the market includes RadNet, Inc. (US), Sonic Healthcare (Australia), Akumin Inc. (US), Healius Limited (Australia), RAYUS Radiology (US), Dignity Health (US), Novant Health (US), Alliance Medical (UK), InHealth Group (UK), Apex Radiology (Australia), Concord Medical Services Holdings Limited (China), Unilabs (Switzerland), Affidea (Netherlands), I-MED Radiology Network (Australia), Capitol Imaging Services (US), SimonMed (US), among others.

Diagnostic Imaging Services Market by Procedure (MRI, Ultrasound, CT, X-RAY, Nuclear Imaging, Mammography), Application (OB/Gyn, Pelvic/Abdomen, Cardiology, Oncology, Neurology), Technology, User (Hospitals, Diagnostic Centers) - Global Forecast to 2027

Research Coverage
This research report categorizes the diagnostic imaging services market, by modality, application, technology, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global diagnostic imaging services market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.


目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 29)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 INCLUSIONS & EXCLUSIONS
1.3.4 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 34)
2.1 RESEARCH METHODOLOGY
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 DIAGNOSTIC IMAGING SERVICES CONSUMPTION-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: OVERALL DIAGNOSTIC IMAGING SERVICES MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 6 DIAGNOSTIC IMAGING SERVICES MARKET: DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 RESEARCH ASSUMPTIONS
2.4.2 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. – 43)
FIGURE 7 DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2022 VS. 2027 (USD BILLION)
FIGURE 8 X-RAY IMAGING MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION)
FIGURE 9 DIAGNOSTIC IMAGING SERVICES MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD BILLION)
FIGURE 10 DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC IMAGING SERVICES MARKET

4 PREMIUM INSIGHTS (Page No. – 47)
4.1 DIAGNOSTIC IMAGING SERVICES MARKET OVERVIEW
FIGURE 12 EARLY DISEASE DETECTION AND RISING INCIDENCE OF AGE-ASSOCIATED DISEASES TO DRIVE MARKET
4.2 DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATION, 2022 VS. 2027 (USD BILLION)
FIGURE 13 CARDIOVASCULAR SEGMENT TO DOMINATE CT MARKET IN 2022
4.3 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER AND COUNTRY
FIGURE 14 HOSPITALS SEGMENT IN EUROPE ACCOUNTED FOR LARGEST SHARE IN 2021
4.4 GEOGRAPHIC SNAPSHOT OF DIAGNOSTIC IMAGING SERVICES MARKET
FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. – 50)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 DIAGNOSTIC IMAGING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising geriatric population and subsequent increase in age-related diseases
TABLE 1 AGE-RELATED DISEASES AND OTHER ASSOCIATED DIAGNOSTIC MODALITIES
5.2.1.2 Growing awareness of early disease detection and broad scope of clinical applications
TABLE 2 EMERGING APPLICATIONS OF DIAGNOSTIC IMAGING
5.2.1.3 Technological advancements in diagnostic imaging
5.2.1.4 Growing preference for outpatient imaging centers
TABLE 3 HOSPITAL PRICES AS A PERCENTAGE OF OUTPATIENT IMAGING PRICES
5.2.2 RESTRAINTS
5.2.2.1 High cost of diagnostic imaging systems
5.2.2.2 Low reimbursement for outpatient imaging facilities
TABLE 4 MEDICARE REIMBURSEMENT TRENDS BY IMAGING MODALITY (2007−2019)
5.2.3 OPPORTUNITIES
5.2.3.1 Adoption of AI and blockchain
5.2.3.2 High growth opportunities in emerging countries
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled radiologists
5.2.4.2 Hospital budget cuts
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE OF DIAGNOSTIC IMAGING SERVICES BY KEY PLAYERS
TABLE 5 MODALITY – MRI SCAN
TABLE 6 MODALITY – CT SAN
TABLE 7 MODALITY – X-RAY
TABLE 8 MODALITY – PET SCAN
TABLE 9 AVERAGE SELLING PRICE OF DIAGNOSTIC IMAGING MODALITY TREND (USD)
5.4 ECOSYSTEM ANALYSIS: DIAGNOSTIC IMAGING SERVICES MARKET
5.5 REGULATORY ANALYSIS
TABLE 10 KEY REGULATORY BODIES & GOVERNMENT AGENCIES
5.5.1 KEY REGULATORY GUIDELINES
5.5.1.1 US
TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.1.2 Canada
TABLE 13 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.1.3 Europe
5.5.1.4 Japan
TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.5.1.5 China
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.5.1.6 India
5.6 REIMBURSEMENT SCENARIO
TABLE 16 MEDICAL REIMBURSEMENT CPT CODES FOR MRI PROCEDURES (AS OF 2022) (US)
TABLE 17 MEDICAL REIMBURSEMENT CPT CODES FOR CT IMAGING PROCEDURES (AS OF 2022) (US)
TABLE 18 MEDICAL REIMBURSEMENT CODES FOR PET/CT IMAGING PROCEDURES (AS OF 2022) (US)
TABLE 19 MEDICAL REIMBURSEMENT CODES FOR ULTRASOUND IMAGING PROCEDURES (AS OF 2021) (US)
TABLE 20 MEDICAL REIMBURSEMENT CODES FOR MAMMOGRAPHY IMAGING PROCEDURES (AS OF 2021) (US)
TABLE 21 MEDICAL REIMBURSEMENT CODES FOR X-RAY IMAGING PROCEDURES (AS OF 2021) (US)
5.6.1 COMMERCIAL REIMBURSEMENT: DIAGNOSTIC IMAGING SERVICES
5.7 VALUE CHAIN ANALYSIS
5.7.1 RESEARCH & DEVELOPMENT
5.7.2 MANUFACTURING & ASSEMBLY
5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
FIGURE 17 VALUE CHAIN ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 OVERVIEW
TABLE 22 DIAGNOSTIC IMAGING SERVICE MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.2 BARGAINING POWER OF BUYERS
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 THREAT OF NEW ENTRANTS
5.8.5 THREAT OF SUBSTITUTES
5.8.6 INTENSITY OF COMPETITIVE RIVALRY
5.9 PATENT ANALYSIS
FIGURE 18 MAJOR PATENT HOLDERS FOR ULTRASOUND IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022)
FIGURE 19 MAJOR PATENT HOLDERS FOR MAGNETIC RESONANCE IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022)
FIGURE 20 MAJOR PATENT HOLDERS FOR CT IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022)
FIGURE 21 MAJOR PATENT HOLDERS FOR MAMMOGRAPHY SYSTEMS (JANUARY 2011 TO AUGUST 2022)
FIGURE 22 MAJOR PATENT HOLDERS FOR NUCLEAR IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022)
FIGURE 23 MAJOR PATENT HOLDERS FOR X-RAY SYSTEMS (JANUARY 2011 TO AUGUST 2022)
FIGURE 24 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIAGNOSTIC IMAGING PATENTS, 2011–2022
5.10 KEY CONFERENCES & EVENTS (2022–2023)
TABLE 23 DIAGNOSTIC IMAGING SERVICES MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 25 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESSES FOR DIFFERENT IMAGING MODALITIES/PROCEDURES
TABLE 24 INFLUENCE OF STAKEHOLDERS PURCHASING SERVICES FOR TOP 3 IMAGING MODALITIES/PROCEDURES (%)
5.13 KEY BUYING CRITERIA, BY END USER
TABLE 25 KEY BUYING CRITERIA FOR BUYING MODALITY SEGMENTS

6 DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY (Page No. – 80)
6.1 INTRODUCTION
TABLE 26 DIAGNOSTIC IMAGING SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION)
TABLE 27 DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
6.2 MAGNETIC RESONANCE IMAGING (MRI)
6.2.1 ACCURATE DISEASE STAGING AND EFFECTIVE RESPONSE IN TREATMENT OF CHRONIC CONDITIONS TO DRIVE MARKET
TABLE 28 MAGNETIC RESONANCE IMAGING SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION)
TABLE 29 MAGNETIC RESONANCE IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
6.3 ULTRASOUND
6.3.1 RISING DEVELOPMENT OF POC ULTRASOUND SYSTEMS TO SUPPORT MARKET GROWTH
TABLE 30 ULTRASOUND SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION)
TABLE 31 ULTRASOUND SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
6.4 COMPUTED TOMOGRAPHY (CT)
6.4.1 RISING ADOPTION OF CT SCANNERS FOR DETECTION OF TUMORS TO SUPPORT MARKET GROWTH
TABLE 32 COMPUTED TOMOGRAPHY SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION)
TABLE 33 COMPUTED TOMOGRAPHY SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
6.5 X-RAY
6.5.1 LOWER COST OF X-RAY IMAGING COMPARED TO OTHER MODALITIES TO DRIVE MARKET
TABLE 34 X-RAY SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION)
TABLE 35 X-RAY SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
6.6 NUCLEAR IMAGING (SPECT/PET)
6.6.1 STRINGENT REGULATIONS AND UNCERTAIN REIMBURSEMENT SCENARIOS TO RESTRAIN MARKET
TABLE 36 NUCLEAR IMAGING SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION)
TABLE 37 NUCLEAR IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
6.7 MAMMOGRAPHY
6.7.1 RISING BREAST CANCER CASES TO DRIVE DEMAND FOR 3D MAMMOGRAMS
TABLE 38 MAMMOGRAPHY SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION)
TABLE 39 MAMMOGRAPHY SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)

7 DIAGNOSTIC IMAGING SERVICES MARKET, BY APPLICATION (Page No. – 91)
7.1 INTRODUCTION
TABLE 40 DIAGNOSTIC IMAGING SERVICES MARKET, BY APPLICATION, 2020–2027 (USD BILLION)
7.2 MAGNETIC RESONANCE IMAGING (MRI)
TABLE 41 DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING, BY APPLICATION, 2020–2027 (USD BILLION)
7.2.1 NEUROLOGY
7.2.1.1 Innovations in 3D MRI technology to have wide applications in neurology
7.2.2 ORTHOPEDICS
7.2.2.1 MRI procedures to be effective in diagnosis & prognosis of musculoskeletal disorders
TABLE 42 MAGNETIC RESONANCE IMAGING SERVICES MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.2.3 CARDIOVASCULAR
7.2.3.1 MRI helps obtain high-resolution images of vascular systems
TABLE 43 MAGNETIC RESONANCE IMAGING SERVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.2.4 PELVIC & ABDOMEN
7.2.4.1 Rising cases of kidney stones among individuals to support market growth
TABLE 44 MAGNETIC RESONANCE IMAGING SERVICES MARKET FOR PELVIC & ABDOMEN APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.2.5 ONCOLOGY
7.2.5.1 Rising prevalence of cancer and increasing awareness of early cancer screening to drive market
7.2.6 OTHER MRI APPLICATIONS
7.3 ULTRASOUND
TABLE 45 DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND, BY APPLICATION, 2020–2027 (USD BILLION)
7.3.1 OBSTETRICS & GYNECOLOGY
7.3.1.1 Rising number of maternity centers and diagnostic clinics to support market
TABLE 46 ULTRASOUND IMAGING SERVICES MARKET FOR OBSTETRICS & GYNECOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.3.2 CARDIOVASCULAR
7.3.2.1 Increasing lifestyle changes and age-related disorders to drive market
TABLE 47 ULTRASOUND IMAGING SERVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.3.3 UROLOGY
7.3.3.1 Growing incidence of urological disorders to support market growth
TABLE 48 ULTRASOUND IMAGING SERVICES MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.3.4 NEUROLOGY
7.3.4.1 Increasing incidence of neuromuscular disorders to drive market
TABLE 49 ULTRASOUND IMAGING SERVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.3.5 ORTHOPEDICS
7.3.5.1 Increasing use of ultrasound in orthopedics due to absence of harmful ionization radiation
TABLE 50 ULTRASOUND IMAGING SERVICES MARKET FOR ORTHOPEDICS APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.3.6 OTHER ULTRASOUND APPLICATIONS
TABLE 51 ULTRASOUND IMAGING SERVICES MARKET FOR OTHER ULTRASOUND APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.4 COMPUTED TOMOGRAPHY (CT)
TABLE 52 DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT), BY APPLICATIONS, 2020–2027 (USD BILLION)
7.4.1 CARDIOVASCULAR
7.4.1.1 Growing availability of cardiac CT devices in imaging to propel market
TABLE 53 COMPUTED TOMOGRAPHY MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.4.2 ONCOLOGY
7.4.2.1 Increasing incidence of cancer to drive market
TABLE 54 COMPUTED TOMOGRAPHY (CT) IMAGING SERVICES MARKET FOR ONCOLOGY APPLICATIONS, BY REGION 2020–2027 (USD BILLION)
7.4.3 NEUROLOGY
7.4.3.1 High prevalence of target diseases to support market growth
TABLE 55 COMPUTED TOMOGRAPHY (CT) IMAGING SERVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION 2020–2027 (USD BILLION)
7.4.4 OTHER COMPUTED TOMOGRAPHY (CT) APPLICATIONS
TABLE 56 COMPUTED TOMOGRAPHY (CT) IMAGING SERVICES MARKET FOR OTHER CT APPLICATIONS, BY REGION 2020–2027 (USD BILLION)
7.5 X-RAY
TABLE 57 DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020–2027 (USD BILLION)
7.5.1 GENERAL RADIOGRAPHY
7.5.1.1 Rising prevalence of lung diseases to drive market
TABLE 58 X-RAY IMAGING SERVICES MARKET FOR GENERAL RADIOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.5.2 DENTISTRY
7.5.2.1 High prevalence of dental disorders to support dental screening
TABLE 59 X-RAY IMAGING SERVICES MARKET FOR DENTISTRY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.5.3 OTHER X-RAY APPLICATIONS
TABLE 60 DIAGNOSTIC IMAGING SERVICES MARKET FOR OTHER X-RAY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.6 NUCLEAR IMAGING SERVICES
TABLE 61 DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING, BY APPLICATIONS, 2020–2027 (USD BILLION)
7.6.1 NEUROLOGY
7.6.1.1 PET system to provide structural and functional information on brain functions
TABLE 62 NUCLEAR IMAGING SERVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.6.2 ONCOLOGY
7.6.2.1 Nuclear imaging systems distinguish benign and malignant tumors
TABLE 63 NUCLEAR IMAGING SERVICES MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.6.3 CARDIOVASCULAR
7.6.3.1 High prevalence of CVD to drive market
TABLE 64 NUCLEAR IMAGING SERVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.6.4 OTHER NUCLEAR IMAGING APPLICATIONS
TABLE 65 NUCLEAR IMAGING SERVICES MARKET FOR OTHER NUCLEAR IMAGING APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)
7.7 MAMMOGRAPHY
7.7.1 RISING CASES OF BREAST CANCER WORLDWIDE TO DRIVE MARKET
TABLE 66 DIAGNOSTIC IMAGING SERVICES FOR MAMMOGRAPHY APPLICATIONS, BY REGION, 2020–2027 (USD BILLION)

8 DIAGNOSTIC IMAGING SERVICES MARKET, BY TECHNOLOGY (Page No. – 115)
8.1 INTRODUCTION
TABLE 67 DIAGNOSTIC IMAGING SERVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD BILLION)
8.2 2D IMAGING TECHNOLOGY
8.2.1 WIDE USAGE OF 2D IMAGING TECHNOLOGY ACROSS HEALTHCARE FACILITIES TO SUPPORT MARKET GROWTH
TABLE 68 DIAGNOSTIC IMAGING SERVICES MARKET FOR 2D IMAGING TECHNOLOGY, BY REGION, 2020–2027 (USD BILLION)
8.3 3D/4D IMAGING TECHNOLOGY
8.3.1 INCREASING NUMBER OF COMPANIES DEVELOPING 3D IMAGING EQUIPMENT TO DRIVE MARKET
TABLE 69 DIAGNOSTIC IMAGING SERVICES MARKET FOR 3D/4D IMAGING TECHNOLOGY, BY REGION, 2020–2027 (USD BILLION)

9 DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER (Page No. – 119)
9.1 INTRODUCTION
TABLE 70 DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
9.2 HOSPITALS
9.2.1 RISING NUMBER OF DIAGNOSTIC IMAGING PROCEDURES PERFORMED IN HOSPITALS TO DRIVE MARKET
TABLE 71 DIAGNOSTIC IMAGING SERVICES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD BILLION)
9.3 DIAGNOSTIC IMAGING CENTERS
9.3.1 GROWING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO DRIVE MARKET
TABLE 72 DIAGNOSTIC IMAGING SERVICES MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2020–2027 (USD BILLION)
9.4 AMBULATORY CARE CENTERS
9.4.1 GROWING NUMBER OF ACCS TO SUPPORT MARKET GROWTH
TABLE 73 DIAGNOSTIC IMAGING SERVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2027 (USD BILLION)
9.5 RESEARCH & ACADEMIA
9.5.1 INCREASING RESEARCH ACTIVITIES IN CLINICAL APPLICATIONS TO SUPPORT MARKET GROWTH
TABLE 74 DIAGNOSTIC IMAGING SERVICES MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2020–2027 (USD BILLION)

10 DIAGNOSTIC IMAGING SERVICES MARKET, BY REGION (Page No. – 125)
10.1 INTRODUCTION
TABLE 75 DIAGNOSTIC IMAGING SERVICES MARKET, BY REGION, 2020–2027 (USD BILLION)
10.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET SNAPSHOT
TABLE 76 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
TABLE 77 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
TABLE 78 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
TABLE 79 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 80 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 81 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 82 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 83 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 84 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
10.2.1 US
10.2.1.1 Increasing volume of diagnostic imaging procedures to drive market
TABLE 85 US: KEY GROWTH MACROINDICATORS
TABLE 86 US: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.2.2 CANADA
10.2.2.1 Rising collaborations and investments by diagnostic imaging companies to support market growth
TABLE 87 CANADA: MAJOR INDICATORS OF MARKET GROWTH
TABLE 88 CANADA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.3 EUROPE
FIGURE 28 EUROPE: CANCER PREVALENCE, BY COUNTRY, 2012–2030
TABLE 89 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
TABLE 90 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
TABLE 91 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 92 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 93 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 94 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 95 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 96 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
10.3.1 GERMANY
10.3.1.1 Rising volume of imaging procedures to drive market
TABLE 97 GERMANY: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.3.2 UK
10.3.2.1 Government initiatives to promote diagnostic imaging services to drive market
TABLE 98 UK: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.3.3 FRANCE
10.3.3.1 High incidence of Alzheimer’s and other neurological conditions to drive demand for MRI scans
TABLE 99 FRANCE: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.3.4 ITALY
10.3.4.1 Rising senior population coupled with an established healthcare system to support market growth
TABLE 100 ITALY: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.3.5 SPAIN
10.3.5.1 Rising expansion of diagnostic imaging service providers to drive market demand
TABLE 101 SPAIN: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.3.6 REST OF EUROPE (ROE)
TABLE 102 REST OF EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: CANCER PREVALENCE, 2012–2030
FIGURE 30 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET SNAPSHOT
TABLE 103 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD BILLION)
TABLE 104 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
TABLE 105 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 106 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 107 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 108 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 109 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 110 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
10.4.1 CHINA
10.4.1.1 Expansion of diagnostic imaging facilities to support market growth
TABLE 111 CHINA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.4.2 JAPAN
10.4.2.1 Rapid adoption of advanced technologies and rising investments in diagnostic imaging procedures to support market growth
TABLE 112 JAPAN: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.4.3 INDIA
10.4.3.1 Rising number of imaging centers and growing target patient pool to support market growth
TABLE 113 INDIA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Rising focus on integration of AI in diagnostic imaging to support market growth
TABLE 114 SOUTH KOREA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.4.5 AUSTRALIA
10.4.5.1 Government funding to increase accessibility of diagnostic imaging services to drive market
TABLE 115 AUSTRALIA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.4.6 REST OF ASIA PACIFIC (ROAPAC)
TABLE 116 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
10.5 LATIN AMERICA
10.5.1 RISING GERIATRIC POPULATION AND INCREASING DISEASE INCIDENCE TO SUPPORT MARKET GROWTH
TABLE 117 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
TABLE 118 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY IMAGING APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 119 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 120 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 121 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 122 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 123 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVEMENTS IN HEALTHCARE SYSTEMS TO SUPPORT MARKET UPTAKE OF DIAGNOSTIC IMAGING SYSTEMS
TABLE 124 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)
TABLE 125 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY IMAGING APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 126 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 127 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 128 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 129 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020–2027 (USD BILLION)
TABLE 130 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020–2027 (USD BILLION)TABLE 116 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020–2027 (USD BILLION)

11 COMPETITIVE LANDSCAPE (Page No. – 166)
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
FIGURE 31 OVERVIEW OF STRATEGIES ADOPTED BY COMPANIES
11.3 REVENUE ANALYSIS
FIGURE 32 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2018−2021)
11.4 DIAGNOSTIC IMAGING SERVICES MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
FIGURE 33 MARKET SHARE ANALYSIS, 2021
TABLE 131 DIAGNOSTIC IMAGING SERVICES MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT FOR MAJOR PLAYERS (AS OF 2021)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 34 DIAGNOSTIC IMAGING SERVICES MARKET: COMPANY EVALUATION QUADRANT (2021)
11.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 35 DIAGNOSTIC IMAGING SERVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
11.7 COMPETITIVE BENCHMARKING
TABLE 132 OVERALL FOOTPRINT ANALYSIS
TABLE 133 MODALITY FOOTPRINT ANALYSIS
TABLE 134 REGIONAL FOOTPRINT ANALYSIS
11.8 COMPETITIVE SCENARIO (2019–2022)
11.8.1 DEALS
11.8.2 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. – 180)
(Business Overview, Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 RADNET, INC.
TABLE 135 RADNET, INC: BUSINESS OVERVIEW
FIGURE 36 RADNET, INC: COMPANY SNAPSHOT (2021)
TABLE 136 RADNET, INC: SERVICE OFFERINGS
12.2 SONIC HEALTHCARE
TABLE 137 SONIC HEALTHCARE: BUSINESS OVERVIEW
FIGURE 37 SONIC HEALTHCARE: COMPANY SNAPSHOT (2021)
TABLE 138 SONIC HEALTHCARE: SERVICE OFFERINGS
12.3 AKUMIN INC.
TABLE 139 AKUMIN INC. BUSINESS OVERVIEW
FIGURE 38 AKUMIN INC: COMPANY SNAPSHOT (2021)
TABLE 140 AKUMIN INC: SERVICE OFFERINGS
12.4 HEALIUS LIMITED
TABLE 141 HEALIUS LIMITED: BUSINESS OVERVIEW
FIGURE 39 HEALIUS LIMITED: COMPANY SNAPSHOT (2021)
TABLE 142 HEALIUS LIMITED: SERVICE OFFERINGS
12.5 DIGNITY HEALTH
TABLE 143 DIGNITY HEALTH: BUSINESS OVERVIEW
FIGURE 40 DIGNITY HEALTH: COMPANY SNAPSHOT (2021)
TABLE 144 DIGNITY HEALTHCARE: SERVICE OFFERINGS
12.6 NOVANT HEALTH
TABLE 145 NOVANT HEALTH: BUSINESS OVERVIEW
FIGURE 41 NOVANT HEALTH: COMPANY SNAPSHOT (2021)
TABLE 146 NOVANT HEALTH: SERVICE OFFERINGS
12.7 ALLIANCE MEDICAL
TABLE 147 ALLIANCE MEDICAL: BUSINESS OVERVIEW
TABLE 148 ALLIANCE MEDICAL: SERVICE OFFERINGS
12.8 INHEALTH GROUP
TABLE 149 INHEALTH GROUP: BUSINESS OVERVIEW
TABLE 150 INHEALTH GROUP: SERVICE OFFERINGS
12.9 APEX RADIOLOGY
TABLE 151 APEX RADIOLOGY: BUSINESS OVERVIEW
TABLE 152 APEX RADIOLOGY: SERVICE OFFERINGS
12.10 CONCORD MEDICAL SERVICES HOLDINGS LIMITED
TABLE 153 CONCORD MEDICAL SERVICES HOLDINGS LIMITED: BUSINESS OVERVIEW
FIGURE 42 CONCORD MEDICAL SERVICES HOLDINGS LIMITED: COMPANY SNAPSHOT (2021)
TABLE 154 CONCORD MEDICAL SERVICES HOLDINGS LIMITED: SERVICE OFFERINGS
12.11 RAYUS RADIOLOGY (CENTER FOR DIAGNOSTIC IMAGING, INC.)
TABLE 155 RAYUS RADIOLOGY: BUSINESS OVERVIEW
TABLE 156 RAYUS RADIOLOGY: SERVICE OFFERINGS
12.12 UNILABS
TABLE 157 UNILABS: BUSINESS OVERVIEW
TABLE 158 UNILABS: SERVICE OFFERINGS
12.13 AFFIDEA
TABLE 159 AFFIDEA: BUSINESS OVERVIEW
TABLE 160 AFFIDEA: SERVICE OFFERINGS
12.14 I-MED RADIOLOGY NETWORK
TABLE 161 I-MED RADIOLOGY NETWORK: BUSINESS OVERVIEW
TABLE 162 I-MED RADIOLOGY NETWORK: SERVICE OFFERINGS
12.15 CAPITOL IMAGING SERVICES
TABLE 163 CAPITOL IMAGING SERVICES: BUSINESS OVERVIEW
TABLE 164 CAPITOL IMAGING SERVICES: SERVICE OFFERINGS
12.16 SIMONMED
TABLE 165 SIMONMED: BUSINESS OVERVIEW
TABLE 166 SIMONMED: SERVICE OFFERINGS
12.17 CANADA DIAGNOSTIC CENTRES (CDC)
TABLE 167 CANADA DIAGNOSTIC CENTRES: BUSINESS OVERVIEW
TABLE 168 CANADA DIAGNOSTIC CENTRES: SERVICE OFFERINGS
12.18 SHIELDS HEALTH CARE GROUP
TABLE 169 SHIELDS HEALTH CARE GROUP: BUSINESS OVERVIEW
TABLE 170 SHIELDS HEALTH CARE GROUP: SERVICE OFFERINGS
12.19 ENVISION RADIOLOGY
TABLE 171 ENVISION RADIOLOGY: BUSINESS OVERVIEW
TABLE 172 ENVISION RADIOLOGY: SERVICE OFFERINGS
12.2 PROGRESSIVE RADIOLOGY
TABLE 173 PROGRESSIVE RADIOLOGY: BUSINESS OVERVIEW
TABLE 174 PROGRESSIVE RADIOLOGY: SERVICE OFFERINGS
12.21 OTHER PLAYERS
12.21.1 QSCAN SERVICES PTY LTD
12.21.2 PRP DIAGNOSTIC IMAGING
12.21.3 INOVA
12.21.4 ATLANTIC MEDICAL IMAGING
12.21.5 ADVANCED DIAGNOSTICS HEALTHCARE SYSTEM, INC.

*Details on Business Overview, Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. – 222)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com